NCT00989703View on ClinicalTrials.gov

GLPG0259 Multiple Ascending Dose and Methotrexate Drug-drug Interaction (DDI) in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

January 31, 2010

Conditions

Healthy

Interventions

DRUG

placebo

oral solution, daily for 14 days

DRUG

GLPG0259

oral solution

DRUG

Methotrexate

7.5 mg (3 tablets, 2.5 mg/tablet) on study days D-1 and D14

Trial Locations (1)

Unknown

SGS Stuivenberg, Antwerp

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galapagos NV

INDUSTRY